Injecta Summit is a leading event uniting professionals from pharma, medical devices, and healthcare to explore advancements in pre-filled syringes, injectable drug devices, and parenteral systems . The summit provides a focused setting to exchange insights on regulatory compliance, patient-centric design, emerging technologies, and sustainability. Ypsomed’s Jakob Lange will present “Device and primary container options for treating obesity with GLP1’s.”
His session will cover market trends, device formats, the sustainability implications of different designs, and what patients want – and why they want it.
Join the conversation in Porto this December.
Our speaker at the conference
Jakob Lange
Jakob Lange is currently VP and head of Account and Business Development with responsibility for Ypsomed's customer relationships and marketing activities. Before his present role, he held different positions within marketing and sales as well as in R&D project management. He has been with Ypsomed for more than 19 years. Jakob holds an MSc degree in Chemical Engineering from the Royal Institute of Technology in Stockholm, Sweden, and a Ph.D. in Polymer Science from the Swiss Federal Institute of Technology in Lausanne, Switzerland. He has written and published more than 40 peer-reviewed papers on medical devices, packaging materials, and polymers.
